Nicholas P Restifo Selected Research

Nicholas P Restifo Research Topics

Disease

172	Neoplasms (Cancer) 01/2022 - 01/2002
74	Melanoma (Melanoma, Malignant) 02/2021 - 01/2002
9	Experimental Melanoma 06/2013 - 08/2004
7	Neoplasm Metastasis (Metastasis) 08/2016 - 06/2002
7	Communicable Diseases (Infectious Diseases) 10/2013 - 04/2005
5	Virus Diseases (Viral Diseases) 11/2019 - 06/2006
4	Inflammation (Inflammations) 07/2017 - 03/2006
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 05/2008
3	Fowlpox 01/2016 - 08/2003
3	Infections 02/2015 - 05/2009
3	Testicular Neoplasms (Testicular Cancer) 10/2011 - 01/2006
2	Weight Loss (Weight Reduction) 01/2020 - 05/2006
2	Autoimmune Diseases (Autoimmune Disease) 07/2017 - 09/2010
2	Colorectal Neoplasms (Colorectal Cancer) 03/2016 - 03/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016 - 12/2014
2	Sarcoma (Soft Tissue Sarcoma) 03/2015 - 03/2011
2	Lymphoma (Lymphomas) 12/2014 - 11/2010
2	Vitiligo 06/2013 - 09/2010
2	Lymphopenia (Lymphocytopenia) 03/2010 - 04/2005
2	Vaccinia 04/2006 - 11/2002
2	Thrombocytopenia (Thrombopenia) 04/2005 - 01/2002
1	Bites and Stings (Sting) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Uterine Cervical Dysplasia 01/2018
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2017
1	Teratoma (Teratoid Tumor) 11/2017
1	Carcinogenesis 11/2017

Drug/Important Bio-Agent (IBA)

63	AntigensIBA 01/2021 - 06/2002
26	Interleukin-2 (IL2)IBA 05/2017 - 08/2003
24	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 02/2004
24	CytokinesIBA 01/2020 - 09/2003
22	VaccinesIBA 05/2017 - 01/2002
18	Peptides (Polypeptides)IBA 01/2019 - 06/2002
14	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 09/2002
14	Proteins (Proteins, Gene)FDA Link 11/2017 - 06/2002
13	EpitopesIBA 01/2019 - 08/2003
12	Chimeric Antigen ReceptorsIBA 01/2021 - 11/2010
9	AutoantigensIBA 05/2017 - 09/2002
8	LigandsIBA 01/2019 - 08/2003
8	InterleukinsIBA 03/2012 - 08/2003
8	Differentiation AntigensIBA 12/2010 - 10/2002
7	Interleukin-12 (IL 12)IBA 01/2020 - 09/2010
7	Interleukin-15 (Interleukin 15)IBA 08/2011 - 02/2004
6	Monophenol Monooxygenase (Tyrosinase)IBA 12/2010 - 04/2006
5	HLA-A*02:01 antigenIBA 03/2015 - 08/2003
4	Glycoproteins (Glycoprotein)IBA 12/2014 - 09/2003
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2013 - 08/2010
4	interferon tauIBA 06/2013 - 03/2004
4	Interleukin-17 (Interleukin 17)IBA 12/2011 - 07/2009
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2009 - 04/2005
4	Cancer VaccinesIBA 05/2006 - 11/2002
3	PotassiumIBA 01/2019 - 01/2016
3	HLA-A Antigens (HLA-A)IBA 01/2018 - 02/2005
3	Transcription Factors (Transcription Factor)IBA 02/2016 - 05/2006
3	Monoclonal AntibodiesIBA 12/2014 - 09/2005
3	Interferon-gamma (Interferon, gamma)IBA 06/2013 - 07/2009
3	DNA VaccinesIBA 10/2011 - 01/2003
3	DisulfidesIBA 10/2011 - 06/2010
3	interleukin-21 (interleukin 21)IBA 08/2011 - 01/2005
3	fludarabineIBA 05/2009 - 04/2005
3	gp100 Melanoma AntigenIBA 11/2005 - 08/2003
2	Histocompatibility Antigens Class IIBA 12/2021 - 01/2019
2	InterferonsIBA 01/2020 - 01/2017
2	Messenger RNA (mRNA)IBA 11/2019 - 01/2006
2	Initiator Codon (Start Codon)IBA 01/2019 - 02/2005
2	Chemokine ReceptorsIBA 05/2017 - 10/2006
2	Oxygen (Dioxygen)IBA 01/2017 - 08/2016
2	Codon (Codons)IBA 03/2016 - 02/2005
2	Toll-Like Receptor AgonistsIBA 01/2016 - 05/2011
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2012 - 11/2010
2	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2011 - 09/2007
2	Protein Subunit VaccinesIBA 07/2010 - 05/2006
2	EnzymesIBA 06/2010 - 01/2003
2	Amino Acids FDA Link 10/2007 - 08/2003
2	DNA (Deoxyribonucleic Acid)IBA 05/2006 - 05/2003
2	Biomarkers (Surrogate Marker)IBA 11/2005 - 09/2004
2	beta 2-Microglobulin (beta 2 Microglobulin)IBA 02/2005 - 09/2003
2	beta-Galactosidase (Lactaid)IBA 11/2002 - 01/2002
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	vadimezanIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2020
1	MorpholinosIBA 11/2019
1	AntibodiesIBA 11/2019
1	Untranslated Regions (Untranslated Region)IBA 01/2019
1	epidermal growth factor receptor VIIIIBA 01/2019
1	Histones (Histone)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018

Therapy/Procedure

91	Immunotherapy 01/2022 - 01/2002
56	Therapeutics 01/2022 - 06/2002
10	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 04/2008
7	Drug Therapy (Chemotherapy) 10/2016 - 09/2003
3	Transplantation 12/2010 - 04/2005
2	Aftercare (After-Treatment) 05/2015 - 05/2009
2	Intravenous Administration 09/2003 - 01/2002
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Radiotherapy 11/2019